choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Biocon Insulin

Biocon Insulin Newsletter
  • Biocon unveils Liraglutide for diabetes, obesity in Netherlands 15 Dec 2025 07:49 GMT

    … Executive Officer and Managing Director, Biocon Limited, said, “The launch … significant milestone in expanding Biocon’s GLP-1 portfolio … another step forward in Biocon’s mission to better … excursions through augmentation of insulin and inhibition of glucagon …

  • Biocon buys out Viatris and others from biosimilar subsidiary 10 Dec 2025 00:17 GMT

    … its biosimilar subsidiary will help Biocon leverage its global commercial infrastructure … company with biosimilar insulins and generic GLP-1 peptides, Biocon is uniquely … blockbuster insulin Lantus, across the regulatory finish line. At the time, Biocon …

  • Indian Biocon intends to buy out minority stakes in Biocon Biologics 08 Dec 2025 16:33 GMT

    … shares of Biocon for 100 shares of Biocon Biologics. Biocon also … The deal will provide Biocon with a competitive advantage, … that produces biosimilars of insulin and generics of complex … (New Jersey, USA). Biocon Biologics is an Indian biopharmaceutical …

  • Biocon Ltd to integrate Biocon Biologics Ltd to create a Unified Global Biopharmaceutical Leader 06 Dec 2025 18:02 GMT

    … integration of Biocon Biologics Limited with Biocon Limited and making Biocon Biologics … insulins and generic versions of complex peptides, including GLP-1s, Biocon … company with biosimilar insulins and generic GLP1 peptides, Biocon is uniquely positioned …

  • Biocon to merge biologics unit; to acquire stake held by Serum, Mylan 06 Dec 2025 12:50 GMT

    … committee, led by Biocon Biologics CEO and Managing … ;The integration of Biocon Biologics into Biocon Limited represents the … biosimilar insulins and generic GLP-1 peptides, Biocon is … insulins and generic versions of complex peptides, including GLP-1s, Biocon …

  • Biocon to make Biocon Biologics a wholly owned arm 06 Dec 2025 11:05 GMT

    … integration of Biocon Biologics Limited with Biocon Limited and making Biocon Biologics … amp; Managing Director at Biocon Limited and Biocon Biologics Limited, respectively, … company with biosimilar insulins and generic GLP1 peptides, Biocon is uniquely …

  • Biocon arm gets tentative FDA nod for Parkinson's treatment capsules carbidopa–levodopa 06 Dec 2025 00:52 GMT

    … its wholly-owned subsidiary, Biocon Pharma Ltd, has received … mg. According to Biocon, carbidopa and levodopa extended … unlisted material subsidiary Biocon Biologics Limited and … Biocon Biologics extends partnership with US non-profit Civica to sell insulin …

  • Biocon board to weigh Biocon Biologics investment, new fundraising plan on December 6 04 Dec 2025 06:06 GMT

    … its unlisted material subsidiary Biocon Biologics Limited and the … a proposal for investment in Biocon Biologics Ltd (BBL) … of the transaction structure, Biocon may issue and allot … Biocon Biologics extends partnership with US non-profit Civica to sell insulin …

  • Insulin Analog Market Forecasting USD 25.29 Billion Valuation by 2034 03 Dec 2025 17:55 GMT

    … of Insulin Aspart in the U.S., a collaboration between Biocon Biologics … by Biocon Biologics to Civica, Inc. for the production of Insulin Aspart … Analogs Long-acting Analogs Insulin Glargine Insulin Detemir Insulin Degludec Ultra-long-acting …

  • Insulin Analog Market Forecasting USD 25.29 Billion Valuation by 2034 03 Dec 2025 16:00 GMT

    … of Insulin Aspart in the U.S., a collaboration between Biocon Biologics … by Biocon Biologics to Civica, Inc. for the production of Insulin Aspart … Analogs Long-acting Analogs Insulin Glargine Insulin Detemir Insulin Degludec Ultra-long-acting …

Satisfied with the content?

Continue to create your account.